Telemedicine as a Therapeutic Option in Gynecologic Cancer Care Management due COVID-19 Pandemics: Cross-Sectional Study among Physicians and Patients
Received Date: Jul 03, 2021 / Accepted Date: Jul 17, 2021 / Published Date: Jul 24, 2021
Abstract
Background: The global incidence in the treatment of people with cancer is increasing. In the COVID-19 pandemic, many consultations had to be cancelled, postponed or converted to a virtual format. Telemedicine serves as a treatment option in other medical disciplines. This study analyses the use and perception of telemedicine as a therapeutic option in gynecologic cancer care management in Germany.
Methods: This prospective cross-sectional study was based on a survey of gynecological oncologists and patients in Germany during the COVID-19 pandemic. Descriptive statistics were calculated. Regression analyses were performed to show correlations.
Results: We analyzed the responses of 529 patients and 402 gynecological oncologists. Most believed that telemedicine is useful. Physicians as well as patients rated their knowledge of telemedicine as unsatisfactory. The majority of respondents said they do not currently use telemedicine, although would like to do so. Patients and physicians reported that their attitude had changed positively towards telemedicine and that their usage had increased due to COVID-19. The majority in both groups agreed on implementing virtual visits in stable disease conditions.
Conclusion: Telemedicine as a therapeutic option in gynecologic cancer care management finds limited use but high acceptance among physicians and patients alike.
Keywords: Health; Telemedicine; Health services research; COVID-19; Gynecological oncology
Citation: Hertling S, Loos FM, Hertling D, Graul I (2021) Telemedicine as a Therapeutic Option in Gynecologic Cancer Care Management due COVID-19 Pandemics: Cross-Sectional Study among Physicians and Patients. J Oncol Res Treat S3:001. Doi: 10.4172/aot.s3.1000001
Copyright: © 2021 Hertling S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
黑料网 Journals
Article Tools
Article Usage
- Total views: 1734
- [From(publication date): 0-2021 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 1251
- PDF downloads: 483